PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Solifenacin - Overactive bladder (adults)

PAD Profile : Solifenacin - Overactive bladder (adults)

Keywords :
antimuscarinics, OAB, urge incontinence, urinary incontinence, urinary frequency, LUTS, urinary urgency, anticholinergics, urinary urgency
Brand Names Include :
Vesicare

Traffic Light Status

Status 1 of 3.

Status :
Green
Important Preferred
Formulations :
  • Tablets
Important Information :
1st line unless contra-indicated
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Status 2 of 3.

Status :
Green (see narrative)
Important
Formulations :
  • Oral suspension
Important Information :
Only for patients with swallowing difficulties. Prescribe as solifenacin 1mg/ml oral SUSPENSION
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Status 3 of 3.

Status :
Non Formulary
Important
Formulations :
  • Oral solution
Important Information :
Prescribe as solifenacin 1mg/ml oral SUSPENSION
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
NFD1
Comments :
No comments returned.
Documents :

Guidelines

The following guidelines are available for this indication.

Other Drugs

Other Indications

No indications returned.

Additional Documents

Committee Recommendations

Date
Committee Name
Narrative
06 March 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The APC supports patients in trialling a treatment break of their overactive bladder medicines.

A "Leaflet for trial of stopping anticholinergics" can be found in the documents section below.

05 July 2023
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

Solifenacin is the 1st line treatment option.

Patients with swallowing difficulties

Solifenacin 1mg/ml oral SUSPENSION sugar free is the preferred option in patients with swallowing difficulties.

Solifenacin 5mg/5ml oral solution is non-formulary due to it being significantly more expensive than the suspension in primary care.

See Selection Tool for locally agreed OAB treatment options

Associated BNF Codes

07. Obstetrics, Gynaecology and Urinary-Tract Disorders
07.04.02. Drugs for urinary frequency enuresis and incontinence
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More